2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acute Kidney Injury Induced by Bothrops Venom: Insights into the Pathogenic Mechanisms

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Acute kidney injury (AKI) following snakebite is common in developing countries and Bothrops genus is the main group of snakes in Latin America. To evaluate the pathogenic mechanisms associated with Bothrops venom nephrotoxicity, we assessed urinary and blood samples of patients after hospital admission resulting from Bothrops snakebite in a prospective cohort study in Northeast Brazil. Urinary and blood samples were evaluated during hospital stay in 63 consenting patients, divided into AKI and No-AKI groups according to the KDIGO criteria. The AKI group showed higher levels of urinary MCP-1 (Urinary monocyte chemotactic protein-1) (median 547.5 vs. 274.1 pg/mgCr; p = 0.02) and urinary NGAL (Neutrophil gelatinase-associated lipocalin) (median 21.28 vs. 12.73 ng/mgCr; p = 0.03). Risk factors for AKI included lower serum sodium and hemoglobin levels, proteinuria and aPTT (Activated Partial Thromboplastin Time) on admission and disclosed lower serum sodium ( p = 0.01, OR = 0.73, 95% CI: 0.57–0.94) and aPTT ( p = 0.031, OR = 26.27, 95% CI: 1.34–512.11) levels as independent factors associated with AKI. Proteinuria showed a positive correlation with uMCP-1 (r = 0.70, p < 0.0001) and uNGAL (r = 0.47, p = 0.001). FE Na (Fractional Excretion of sodium) correlated with uMCP-1 (r = 0.47, P = 0.001) and uNGAL (r = 0.56, p < 0.0001). sCr (serum Creatinine) showed a better performance to predict AKI (AUC = 0.85) in comparison with new biomarkers. FE K showed fair accuracy in predicting AKI (AUC = 0.92). Coagulation abnormality was strongly associated with Bothrops venom-related AKI. Urinary NGAL and MCP-1 were good biomarkers in predicting AKI; however, sCr remained the best biomarker. FE K (Fractional Excretion of potassium) emerged as another diagnostic tool to predict early AKI. Positive correlations between uNGAL and uMCP-1 with proteinuria and FE Na may signal glomerular and tubular injury. Defects in urinary concentrations highlighted asymptomatic abnormalities, which deserve further study.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

          Jun Panee (2012)
          Monocyte Chemoattractant Protein-1 (MCP-1) is the first discovered and most extensively studied CC chemokine, and the amount of studies on its role in the etiologies of obesity- and diabetes-related diseases have increased exponentially during the past two decades. This review attempted to provide a panoramic perspective of the history, regulatory mechanisms, functions, and therapeutic strategies of this chemokine. The highlights of this review include the roles of MCP-1 in the development of obesity, diabetes, cardiovascular diseases, insulitis, diabetic nephropathy, and diabetic retinopathy. Therapies that specifically or non-specifically inhibit MCP-1 overproduction have been summarized. Copyright © 2012 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            The Rise and Fall of NGAL in Acute Kidney Injury

            For many years, neutrophil gelatinase-associated lipocalin (NGAL) has been considered the most promising biomarker of acute kidney injury (AKI). Commercial assays and point-of-care instruments, now available in many hospitals, allow rapid NGAL measurements intended to guide the clinician in the management of patients with or at risk of AKI. However, these assays likely measure a mixture of different NGAL forms originating from different tissues. Systemic inflammation, commonly seen in critically ill patients, and several comorbidities contribute to the release of NGAL from haematopoietic and non-haematopoietic cells. The unpredictable release and complex nature of the molecule and the inability to specifically measure NGAL released by tubular cells have hampered its use a specific marker of AKI in heterogeneous critically ill populations. In this review, we describe the nature and cellular sources of NGAL, its biological role and diagnostic ability in AKI and the increasing concerns surrounding its diagnostic and clinical value.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy.

              We previously described that monocyte chemoattractant protein-1 (MCP-1) plays an important role in progressive glomerular and interstitial damage in inflammatory renal diseases. However, the expression of MCP-1 in diabetic nephropathy remains to be investigated. We examined whether locally expressed MCP-1 participates in human diabetic nephropathy via recruiting and activating monocytes/macrophages (Mphi). Urinary and serum MCP-1 levels were measured by enzyme-linked immunosorbent assay in 45 patients with diabetic nephropathy. The presence of MCP-1 in diseased kidneys was determined by immunohistochemical and in situ hybridization analyses. Urinary MCP-1 levels were significantly elevated in patients with diabetic nephrotic syndrome and advanced tubulointerstitial lesions. Moreover, urinary levels of MCP-1 were well correlated with the number of CD68-positive infiltrating cells in the interstitium. In contrast, serum MCP-1 levels remained similar to those of healthy volunteers. Furthermore, we detected the MCP-1-positive cells in the interstitium of diabetic nephropathy via both immunohistochemical and in situ hybridization analyses. These observations suggest that locally produced MCP-1 may be involved in the development of advanced diabetic nephropathy, especially in the formation of tubulointerstitial lesions possibly through Mphi recruitment and activation. Moreover, up-regulation of MCP-1 may be a common pathway involved in the progressive tubulointerstitial damage in diabetic nephropathy as well as inflammatory renal diseases.
                Bookmark

                Author and article information

                Journal
                Toxins (Basel)
                Toxins (Basel)
                toxins
                Toxins
                MDPI
                2072-6651
                05 March 2019
                March 2019
                : 11
                : 3
                : 148
                Affiliations
                [1 ]Medical Sciences of Post-Graduate Program, Department of Internal Medicine, Federal University of Ceara, CEP 60416-200 Fortaleza, Ceara, Brazil; gdayllon@ 123456yahoo.com.br (G.C.M.); ef.daher@ 123456uol.com.br (E.D.F.D.)
                [2 ]School of Medicine, Public Health and Medical Sciences Post-Graduate Programs, School of Medicine, University of Fortaleza, CEP 60811-905 Fortaleza, Ceara, Brazil; geraldobezerrajr@ 123456yahoo.com.br
                [3 ]Center for Toxicological Assistance, Dr. José Frota Institute, CEP 60025-061 Fortaleza, Ceara, Brazil
                [4 ]Pharmacology and Pharmaceutial Sciences Post-Graduate Programs, Federal University of Ceara, CEP 60430-275 Fortaleza, Ceara, Brazil; martinsalice@ 123456gmail.com (A.M.C.M.); danya.dbl@ 123456gmail.com (D.B.L.)
                [5 ]Clinical Pharmacology, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia; jacques.raubenheimer@ 123456sydney.edu.au (J.R.); fathimashihana20@ 123456gmail.com (S.F.); nicholas.buckley@ 123456sydney.edu.au (N.B.)
                Author notes
                [* ]Correspondence: polianna.moreira@ 123456ijf.fortaleza.ce.gov.br ; Tel.: +55-85-3477-3280 or +55-85-3477-3424
                Author information
                https://orcid.org/0000-0002-8971-0994
                https://orcid.org/0000-0003-3907-304X
                https://orcid.org/0000-0002-6362-1221
                https://orcid.org/0000-0002-6326-4711
                https://orcid.org/0000-0003-4189-1738
                Article
                toxins-11-00148
                10.3390/toxins11030148
                6468763
                30841537
                9d837f93-9b22-4685-b51d-b5a113a999ff
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 26 January 2019
                : 28 February 2019
                Categories
                Article

                Molecular medicine
                bothrops,envenomation,acute kidney injury,renal tubular dysfunction,coagulopathy,novel biomarkers

                Comments

                Comment on this article